Journals / Journal of Contemporary Medicine / 2019 / Cilt: 9 - Sayı: 4

Could beta blocker use in elderly hypertensive patients reduce risk of skin cancers?

Yaşlı Hipertensif Hastalarda Kullanılan Beta Blokerler Cilt Kanserlerinin Riski Azaltır Mı?

Pages
311–314
Publication Date
2019-12-31
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Beta blokers are commonly used medications mainly in the treatment of cardiovascular health problems for years.Other known indications are migraine,anxiety,thyrotoxicosis and infantile hemangiomas.In addition to these,recent studies showes they have anticancer properties probably due to their adrenergic and angiogenesis blocking effects which are essential for tumor progression.Patients with prostate,breast,ovarian,non-small cell lung cancers or melanoma were demonstrated getting benefit from beta blocer treatments.Depending on these data,we searched antihypertensive drug history of patients with premalignant skin lesions and non-melanoma akin cancers at past two years.We observed that patients using beta blockers as antihypertensive agent had less solar keratosis and basal cell cancers during the our study.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Beta blokers are commonly used medications mainly in the treatment of cardiovascular health problems for years.Other known indications are migraine,anxiety,thyrotoxicosis and infantile hemangiomas.In addition to these,recent studies showes they have anticancer properties probably due to their adrenergic and angiogenesis blocking effects which are essential for tumor progression.Patients with prostate,breast,ovarian,non-small cell lung cancers or melanoma were demonstrated getting benefit from beta blocer treatments.Depending on these data,we searched antihypertensive drug history of patients with premalignant skin lesions and non-melanoma akin cancers at past two years.We observed that patients using beta blockers as antihypertensive agent had less solar keratosis and basal cell cancers during the our study.
📊
Key Findings & Data:Beta blokers are commonly used medications mainly in the treatment of cardiovascular health problems for years.Other known indications are migraine,anxiety,thyrotoxicosis and infantile hemangiomas.In addition to these,recent studies showes they have anticancer properties probably due to their adrenergic and angiogenesis blocking effects which are essential for tumor progression.Patients with prostate,breast,ovarian,non-small cell lung cancers or melanoma were demonstrated getting benefit from beta blocer treatments.Depending on these data,we searched antihypertensive drug history of patients with premalignant skin lesions and non-melanoma akin cancers at past two years.We observed that patients using beta blockers as antihypertensive agent had less solar keratosis and basal cell cancers during the our study.
💡
Conclusion & Impact:Beta blokers are commonly used medications mainly in the treatment of cardiovascular health problems for years.Other known indications are migraine,anxiety,thyrotoxicosis and infantile hemangiomas.In addition to these,recent studies showes they have anticancer properties probably due to their adrenergic and angiogenesis blocking effects which are essential for tumor progression.Patients with prostate,breast,ovarian,non-small cell lung cancers or melanoma were demonstrated getting benefit from beta blocer treatments.Depending on these data,we searched antihypertensive drug history of patients with premalignant skin lesions and non-melanoma akin cancers at past two years.We observed that patients using beta blockers as antihypertensive agent had less solar keratosis and basal cell cancers during the our study.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Beta blockers · Skin cancer

Abstract

Beta blokers are commonly used medications mainly in the treatment of cardiovascular health problems for years.Other known indications are migraine,anxiety,thyrotoxicosis and infantile hemangiomas.In addition to these,recent studies showes they have anticancer properties probably due to their adrenergic and angiogenesis blocking effects which are essential for tumor progression.Patients with prostate,breast,ovarian,non-small cell lung cancers or melanoma were demonstrated getting benefit from beta blocer treatments.Depending on these data,we searched antihypertensive drug history of patients with premalignant skin lesions and non-melanoma akin cancers at past two years.We observed that patients using beta blockers as antihypertensive agent had less solar keratosis and basal cell cancers during the our study.

Özet

Beta blokerler çoğunlukla yıllarca kardiyovasküler sağlık sorunlarının tedavisinde kullanılan ilaçlardır.Diğer bilinen endikasyonları migren, anksiyete, tirotoksikoz ve infantil hemanjiyomlardır. Bunlara ek olarak, son çalışmalar, muhtemelen tümör ilerlemesi için gerekli olan adrenerjik ve anjiyogenez bloke edici etkileri nedeniyle antikanser özelliklere sahip olduğunu göstermektedir. Prostat, meme, yumurtalık, küçük hücreli dışı akciğer kanserleri veya melanoması olan hastaların beta bloker tedavilerden yararlandıkları gösterilmiştir. Bu verilere bağlı olarak, son iki yılda premalign cilt lezyonları ve melanom dışı cilt kanserli hastaların antihipertansif ilaç öyküsünü araştırdık. Çalışmamızda antihipertansif ajan olarak beta bloker kullanan hastaların daha az solar keratoz ve bazal hücre kanserleri olduğunu gördük.

🔖

Cite This Article

AKTAS, H., TERZİ, E. (2019). Could beta blocker use in elderly hypertensive patients reduce risk of skin cancers?. Journal of Contemporary Medicine, Cilt: 9 - Sayı: 4, 311–314. https://ajindex.com/articles/775211

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (18)

  1. Schmitt JV,Miot HA.Actinic keratosis: a clinical and epidemiological revision.An Bras Dermatol.2012
  2. 87,425-34. 2.Sun Z.Aging, arterial stiffness, and hypertension.Hypertension.2015
  3. 65,252-6. 3.Sipahi I,Debanne SM,Rowland DY,et al.Angiotensin-receptor blockade and risk ofcancer: meta-analysis of randomised controlled trials.Lancet Oncol.2010
  4. 11,627-36. 4.Bangalore S,Kumar S,Kjeldsen SE,et al.Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324,168 participants from randomised trials.Lancet Oncol.2011
  5. 12,65-82. 5.Akbar S,Alsharidah MS.Are beta blockers new potential anticancer agents?Asian Pac J Cancer Prev.2014
  6. 15,9567-74. 6.Melhem-Bertrandt A,et al.Beta-blocker use is associated with improved relapse-free survival in patients with triple-negative breast cancer.J Clin Oncol.2011
  7. 29,2645-52. 7.De Giorgi V, Gandini S, Grazzini M, et al.β-blockers: a new and emerging treatment for melanoma.Recenti Prog Med.2012
  8. 103,11-6. 8.Hwa YL, Shi Q, Kumar SK, Lacy MQ, et al.Beta-blockers improve survival outcomes in patients with multiple myeloma: a retrospective evaluation. Am J Hematol.2017
  9. 92,50-55. 9.Grytli HH, Fagerland MW, Fosså SD,et al.Use of β-blockers is associated with prostate cancer specific survival in prostate cancer patients on androgen deprivation therapy.Prostate,2013
  10. 73,250–607. 10.Huang KM,et al.Topically Applied Carvedilol Attenuates Solar Ultraviolet Radiation InducedSkin Carcinogenesis.Cancer Prev Res (Phila).2017
  11. 10,598-606. 11.Joel L. Cohen.Actinic Keratosis Treatment as a Key Component of Preventive Strategies for Nonmelanoma Skin Cancer.J Clin Aesthet Dermatol.2010
  12. 3, 39–44. 12.Robles NR, Macias JF.Hypertension in the elderly.Cardiovasc Hematol Agents Med Chem.2015
  13. 12,135. 13.Weir MR.Beta-blockers in the treatment of hypertension: are there clinically relevant differences?Postgrad.2009
  14. Akbar S,Alorainy MS.The current status of beta blockers' use in the management of hypertension.Saudi Med J.2014
  15. 35,1307-17. 15.Pantziarka P,Bouche G,Sukhatme V,et al.Repurposing Drugs in Oncology (ReDO)-Propranolol as an anti-cancer agent.E cancer medical science.2016
  16. 12,10,680. 16.He JJ et al. Activation of β-adrenergic receptor promotes cellular proliferation in human glioblastoma.Oncol Lett.2017
  17. 14,3846-3852. 17.Lin X,Luo K,Lv Z,Huang J.β-adrenoceptor action on pancreatic cancer cell proliferation and tumor growth in mice.Hepatogastroenterology.2012
  18. 59,584-8. 18.Hondermarck H,Jobling P.The Sympat